We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Genfit | TG:XUP | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
0.00 | 0.00% | 3.82 | 0.00 | 10:36:40 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
3.77 | 3.805 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | 0 | 3.82 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
13/11/2024 | 21:10 | UKREG | GENFIT fait un point d’actualité sur ses activités à l’occasion de sa.. |
13/11/2024 | 21:10 | UKREG | GENFIT Announces Corporate Updates and Upcoming Participation at The Liver.. |
07/11/2024 | 21:10 | UKREG | GENFIT Reports Third Quarter 2024 Financial Information |
07/11/2024 | 21:10 | UKREG | GENFIT : Information financière du troisième trimestre 2024 |
23/9/2024 | 05:30 | UKREG | GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a.. |
23/9/2024 | 05:30 | UKREG | GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que.. |
19/9/2024 | 20:10 | UKREG | GENFITÂ Reports First Half-Year 2024 Financial Results and Provides.. |
19/9/2024 | 20:10 | UKREG | GENFIT : Résultats financiers du premier semestre 2024 et point sur les.. |
26/7/2024 | 11:45 | UKREG | GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo®.. |
26/7/2024 | 11:45 | UKREG | GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour.. |
Genfit (XUP) Share Charts1 Year Genfit Chart |
|
1 Month Genfit Chart |
Intraday Genfit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions